| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d98762490c9bfd1551fefe55f49ea2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2241aa1044fb0713119bc64b16ae7d33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef70b43d229e99fa27d7991a26b6add9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G81-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 |
| filingDate |
2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a9ca08879c645de4c0867b6e49263b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25bcedc237d1ffa75fcc26590717713e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31530ba6e693f92506ee19349ccc5921
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed2fcf2be814395dd9afb65b72a33866 |
| publicationDate |
2016-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160036866-A |
| titleOfInvention |
MRI Contrast Agent for Contrasting Cancer Cell |
| abstract |
The present invention relates to an MRI contrast agent composition for cancer cell imaging containing ultrafine nanoparticles. More particularly, the present invention relates to a self-assembling ligand composition comprising a ligand A separated at a hydrogen ion concentration (pH) condition of a certain range and a ligand B whose surface charge changes at a hydrogen ion concentration range of a specific range, A MRI contrast agent composition for cancer cell imaging comprising a ligand composition and MRI contrast-enhanced nanoparticles, and a method of producing the same. |
| priorityDate |
2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |